Cargando…
Diagnosing risk factors alongside mass drug administration using serial diagnostic tests—which test first?
BACKGROUND: When tests are used in series to determine individual risk factors and infection status in a mass drug administration (MDA), the diagnostics, test order and subsequent treatment decisions (the testing algorithm) affect population-level treatment coverage and cost, but there is no existin...
Autores principales: | Dyson, Louise, Hollingsworth, T Déirdre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063283/ https://www.ncbi.nlm.nih.gov/pubmed/30020529 http://dx.doi.org/10.1093/trstmh/try062 |
Ejemplares similares
-
Measuring and modelling the effects of systematic non-adherence to mass drug administration
por: Dyson, Louise, et al.
Publicado: (2017) -
Pediatric drug hypersensitivity: which diagnostic tests?
por: Francesca, Saretta, et al.
Publicado: (2019) -
Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope
por: Turner, Hugo C, et al.
Publicado: (2018) -
The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
por: Anderson, Roy, et al.
Publicado: (2014) -
Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
por: Collyer, Benjamin S., et al.
Publicado: (2019)